نتایج جستجو برای: plerixafor

تعداد نتایج: 455  

2011
David H McDermott Joseph Lopez Francis Deng Qian Liu Teresa Ojode Haoqian Chen Jean Ulrick Nana Kwatemaa Corin Kelly Sandra Anaya-O’Brien Mary Garofalo Martha Marquesen Dianne Hilligoss Rosamma DeCastro Harry L Malech Philip M Murphy

WHIM is an acronym for a rare immunodeficiency syndrome (OMIM #193670) caused by autosomal dominant mutations truncating the C-terminus of the chemokine receptor CXC chemokine receptor 4 (CXCR4). WHIM mutations may potentiate CXCR4 signalling, suggesting that the United States Food and Drug Administration (FDA)-approved CXCR4 antagonist AnorMED3100 (AMD3100) (also known as Plerixafor) may be be...

2016
Manoj K. Kashyap Deepak Kumar Harrison Jones Carlos I. Amaya-Chanaga Michael Y. Choi Johanna Melo-Cardenas Amine Ale-Ali Michelle R. Kuhne Peter Sabbatini Lewis J. Cohen Suresh G. Shelat Laura Z. Rassenti Thomas J. Kipps Pina M. Cardarelli Januario E. Castro

The CXCR4 receptor (Chemokine C-X-C motif receptor 4) is highly expressed in different hematological malignancies including chronic lymphocytic leukemia (CLL). The CXCR4 ligand (CXCL12) stimulates CXCR4 promoting cell survival and proliferation, and may contribute to the tropism of leukemia cells towards lymphoid tissues. Therefore, strategies targeting CXCR4 may constitute an effective therape...

2013
Bikash Debnath Shili Xu Fedora Grande Antonio Garofalo Nouri Neamati

CXCR4 is a G-protein-coupled receptor involved in a number of physiological processes in the hematopoietic and immune systems. The SDF-1/CXCR4 axis is significantly associated with several diseases, such as HIV, cancer, WHIM syndrome, rheumatoid arthritis, pulmonary fibrosis and lupus. For example, CXCR4 is one of the major co-receptors for HIV entry into target cells, while in cancer it plays ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید